Spruce Biosciences Inc
(SPRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 4,911 | 10,089 | 0 | 0 | 0 |
| Gross Profit | 4,911 | 10,089 | N/A | N/A | N/A |
| Operating Expenses | 61,062 | 62,082 | 47,283 | 42,066 | 29,416 |
| Operating Income | -56,151 | -51,993 | -47,283 | -42,066 | -29,416 |
| Interest Expense | 307 | 483 | 420 | 345 | 323 |
| Other Income | 3,422 | 4,557 | 1,523 | 119 | 200 |
| Pre-tax Income | -53,036 | -47,919 | -46,180 | -42,292 | -29,539 |
| Net Income Continuous | -53,036 | -47,919 | -46,180 | -42,292 | -29,539 |
| Net Income | $-53,036 | $-47,919 | $-46,180 | $-42,292 | $-29,539 |
| EPS Basic Total Ops | -96.99 | -93.23 | -147.37 | -136.09 | -370.68 |
| EPS Basic Continuous Ops | -96.64 | -93.56 | -147.58 | -136.12 | -370.72 |
| EPS Diluted Total Ops | -96.99 | -93.23 | -147.37 | -136.09 | -370.68 |
| EPS Diluted Continuous Ops | -96.64 | -93.56 | -147.58 | -136.12 | -370.72 |
| EPS Diluted Before Non-Recurring Items | -96.99 | -93.23 | -147.37 | -136.09 | -370.68 |
| EBITDA(a) | $-56,105 | $-52,559 | $-47,193 | $-41,877 | $-29,380 |